力诺药包11月12日获融资买入392.98万元，融资余额1.30亿元

Core Insights - Linuo Pharmaceutical Packaging Co., Ltd. experienced a slight increase in stock price by 0.64% on November 12, with a trading volume of 66.55 million yuan [1] - The company reported a financing buy-in amount of 3.93 million yuan and a financing repayment of 8.51 million yuan on the same day, resulting in a net financing buy of -4.58 million yuan [1] - As of November 12, the total financing and securities lending balance for Linuo Pharmaceutical was 130 million yuan, which accounts for 3.12% of its circulating market value [1] Financing Overview - On November 12, Linuo Pharmaceutical had a financing buy-in of 3.93 million yuan, with a current financing balance of 130 million yuan, exceeding the 60th percentile level over the past year [1] - The company had no securities lending activity on November 12, with a securities lending balance of 0.00 shares, indicating a high level of inactivity in this area [1] Company Profile - Linuo Pharmaceutical, established on March 1, 2002, and listed on November 11, 2021, is located in Shandong Province, China [1] - The company's main business involves the research, production, and sales of special glass, focusing on the development and application of borosilicate glass [1] - The revenue composition of Linuo Pharmaceutical includes 57.02% from heat-resistant glass, 40.74% from pharmaceutical glass, and 2.24% from material sales and others [1] Financial Performance - As of September 30, 2025, Linuo Pharmaceutical reported a total revenue of 721 million yuan, a year-on-year decrease of 13.22%, and a net profit attributable to shareholders of 50.88 million yuan, down 27.80% year-on-year [2] - The company has distributed a total of 139 million yuan in dividends since its A-share listing, with 92.18 million yuan distributed over the past three years [2] Shareholder Structure - As of September 30, 2025, the number of shareholders for Linuo Pharmaceutical increased by 58.60% to 17,600 [2] - The average number of circulating shares per shareholder decreased by 36.94% to 13,571 shares [2] - New institutional shareholders include Rongtong Health Industry Flexible Allocation Mixed A/B and Green High Dividend Preferred Mixed A, among others [2]